Drug firm on Tuesday reported a 64 percent rise in its consolidated net profit to Rs 177 crore for the quarter ended December mainly on account of robust sales.
The company had posted a net profit of Rs 108 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a BSE filing.
Consolidated revenue from operations of the company stood at Rs 749 crore for the quarter under consideration. It was Rs 651 crore for the same period a year ago, it added.
Shares of Ajanta Pharma closed at Rs 1,746.15 apiece on the BSE, down 0.59 percent from its previous close.